Ledger.Open graph →

SEC Form D · filed September 19, 2022

DermBiont, Inc

Offering

—

Sold

$2.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Nichola R. Eliovits · Burlington, MAExec · Director Wilder R. Ramsey · Boston, MADirector Max R. Dawson · Boston, MAExec Steven R. Basta · Boston, MADirector Jennifer R. Lee · Boston, MADirector Karl R. Beutner · Boston, MAExec · Director Adam Frisch · Roswell, GAExec Adil Rahmathulla · Miami, FLDirector Gautam Bhandari · Miami, FLDirector Vaughn Himes · Vancouver, British Columbia, CanadaDirector Nicholas A. Colonna · Westlake, TXExec · Director Sadek Wahba · Miami, FLExec · Director Christopher Stuart · San Antonio, TXDirector Sam Knoury · San Antonio, TXDirector Chris A. Dantin · San Antonio, TXExec · Director Tara Jeschke · Tinley Park, ILExec · Director Daniel C. Nester · Waterloo, ILDirector Pierre Mordacq · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗